FDA Inspection 972661 — Nuvisan GmbH
The FDA completed an inspection of Nuvisan GmbH on Apr 26, 2016 in Waltrop. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Apr 26, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Waltrop (Germany)
Citations
| ID | CFR | Description |
|---|---|---|
| 1263 | 21 CFR 211.68(b) | Computer control of master formula records |
| 2008 | 21 CFR 211.186(a) | Written procedures followed |
| 3603 | 21 CFR 211.160(b) | Scientifically sound laboratory controls |